Is increasing the dose of Entecavir effective in partial virological responders? - Wikidata - wikimedia - TriplyDB

Is increasing the dose of Entecavir effective in partial virological responders?

Is increasing the dose of Entecavir effective in partial virological responders?

http://www.wikidata.org/entity/Q40385406

about

Severe de novo Hepatitis B Recovered from Late-Onset Liver Insufficiency with Prolonged Ascites and Hypoalbuminemia due to Hepatitis B Virus Genotype Bj with Precore Mutation.

P2860

Q37434926-F5249210-74D5-48B2-B063-F0E2196C3F99

P2860

Is increasing the dose of Entecavir effective in partial virological responders?

http://www.wikidata.org/entity/Q40385406

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Is increasing the dose of Entecavir effective in partial virological responders?

@en

type

label

Is increasing the dose of Entecavir effective in partial virological responders?

@en

prefLabel

Is increasing the dose of Entecavir effective in partial virological responders?

@en

P1433

Q40385406-B94EFAEB-3235-4305-B096-DE63FD3877E0

P1476

Q40385406-ADC74861-E541-404F-999E-7715E6831E4D

P2093

Q40385406-34C4F8E1-ABA2-4606-9822-A091F98E0B76

Q40385406-4A659DC9-D47C-45C1-8752-3CB938CB9012

Q40385406-D6E7D5E1-6747-464E-A536-CDDB525B903A

P2860

Q40385406-06577F14-CEDB-4D6E-8DA3-329864A48F12

Q40385406-14E7681E-375B-434F-8CBA-A27359F0BB1F

Q40385406-3B34206F-D65D-4781-BA1C-11C1777876B2

Q40385406-47203876-4C06-4794-922B-1E4997271DD9

Q40385406-6FA76E60-D039-4F41-91DA-477FB1A47BD6

Q40385406-7DC2BEC4-7F36-43DD-8245-EDD386B7DF64

Q40385406-86933849-35BD-4DDA-B69F-F5B5BB1C2A06

Q40385406-90EEA8AC-93BA-480B-BC2F-D76D2C7383EF

Q40385406-976A5793-77B3-4311-A47D-CF4C42CAE8EA

Q40385406-9B08CAA7-DAEB-413A-8FEA-13F8ACAF3EE7

P304

Q40385406-6DAE9FBE-8C83-462F-B4E6-482176DECA81

P31

Q40385406-ECC4054F-E905-4BE1-9E12-09243E00BE8D

P356

Q40385406-D8640C62-C7EB-4DB6-A892-E6D57DE251BE

P407

Q40385406-DB4893F3-9638-4903-A251-038E999F825E

P478

Q40385406-39BABFFE-A668-4B7D-9DEB-D37EAFF89731

P50

Q40385406-52CCF9D5-6C78-4C13-AC6A-44630798CF26

Q40385406-D71FE921-1D81-4898-941F-49BC36B9D7B4

Q40385406-EC667B02-3502-4774-853A-595C9DB6D661

P577

Q40385406-531D0D2E-CA84-4986-BA19-CFBC595853EA

P5875

Q40385406-38972695-32A6-4D39-BDE2-316118F09CE8

P698

Q40385406-A84077AC-DE72-4548-B351-BFA53AC95A5D

P921

Q40385406-5E23F040-583E-4180-AABF-D3A619315A82

P932

Q40385406-5E9A8C53-47E9-4D36-9FAB-FB820AF9F625

P356

P1433

Drug Design, Development and Therapy

P1476

Is increasing the dose of Entecavir effective in partial virological responders?

@en

P2093

Cinar Ozturk

http://www.w3.org/2001/XMLSchema#string

Emine Parlak

http://www.w3.org/2001/XMLSchema#string

Remzi Adnan Akdogan

http://www.w3.org/2001/XMLSchema#string

P2860

Long-term follow-up of patients with anti-HBe/HBV DNA-positive chronic hepatitis B treated for 12 months with lamivudine

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy.

A Systematic Review of Side Effects of Nucleoside and Nucleotide Drugs Used for Treatment of Chronic Hepatitis B.

Treatment of chronic hepatitis B: Evolution over two decades.

Entecavir: a review of its use in the treatment of chronic hepatitis B in patients with decompensated liver disease.

First-line treatment of chronic hepatitis B with entecavir or tenofovir in 'real-life' settings: from clinical trials to clinical practice

Similar response to entecavir 0.5 and 1.0 mg in treatment-naïve chronic hepatitis B patients: a case-control study.

Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B.

Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B.

P304

621-625

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/DDDT.S61045

http://www.w3.org/2001/XMLSchema#string

P407

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Medine Cumhur Cure

P577

2014-05-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263205508

http://www.w3.org/2001/XMLSchema#string

P698

24936126

http://www.w3.org/2001/XMLSchema#string

P921

P932

4047834

http://www.w3.org/2001/XMLSchema#string